312 related articles for article (PubMed ID: 29356040)
21. Downregulation of miRNA-30c and miR-203a is associated with hepatitis C virus core protein-induced epithelial-mesenchymal transition in normal hepatocytes and hepatocellular carcinoma cells.
Liu D; Wu J; Liu M; Yin H; He J; Zhang B
Biochem Biophys Res Commun; 2015 Sep; 464(4):1215-1221. PubMed ID: 26210453
[TBL] [Abstract][Full Text] [Related]
22. CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells.
Wang SJ; Cui HY; Liu YM; Zhao P; Zhang Y; Fu ZG; Chen ZN; Jiang JL
Oncotarget; 2015 Jan; 6(1):243-57. PubMed ID: 25428919
[TBL] [Abstract][Full Text] [Related]
23. Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma.
Fransvea E; Mazzocca A; Antonaci S; Giannelli G
Hepatology; 2009 Mar; 49(3):839-50. PubMed ID: 19115199
[TBL] [Abstract][Full Text] [Related]
24. Dual β-Catenin and γ-Catenin Loss in Hepatocytes Impacts Their Polarity through Altered Transforming Growth Factor-β and Hepatocyte Nuclear Factor 4α Signaling.
Pradhan-Sundd T; Liu S; Singh S; Poddar M; Ko S; Bell A; Franks J; Huck I; Stolz D; Apte U; Ranganathan S; Nejak-Bowen K; Monga SP
Am J Pathol; 2021 May; 191(5):885-901. PubMed ID: 33662348
[TBL] [Abstract][Full Text] [Related]
25. Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis.
Zhou WJ; Geng ZH; Chi S; Zhang W; Niu XF; Lan SJ; Ma L; Yang X; Wang LJ; Ding YQ; Geng JG
Cell Res; 2011 Apr; 21(4):609-26. PubMed ID: 21283129
[TBL] [Abstract][Full Text] [Related]
26. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
27. Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Bacigalupo ML; Manzi M; Espelt MV; Gentilini LD; Compagno D; Laderach DJ; Wolfenstein-Todel C; Rabinovich GA; Troncoso MF
J Cell Physiol; 2015 Jun; 230(6):1298-309. PubMed ID: 25469885
[TBL] [Abstract][Full Text] [Related]
28. Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasiveness.
Wan S; Meyer AS; Weiler SME; Rupp C; Tóth M; Sticht C; Singer S; Thomann S; Roessler S; Schorpp-Kistner M; Schmitt J; Gretz N; Angel P; Tschaharganeh DF; Marquardt J; Schirmacher P; Pinna F; Breuhahn K
Hepatology; 2018 May; 67(5):1842-1856. PubMed ID: 29152770
[TBL] [Abstract][Full Text] [Related]
29. Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma.
Li X; Zhang Y; Ma W; Fu Q; Liu J; Yin G; Chen P; Dai D; Chen W; Qi L; Yu X; Xu W
Cancer Immunol Immunother; 2020 Apr; 69(4):535-548. PubMed ID: 31965268
[TBL] [Abstract][Full Text] [Related]
30. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
31. Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1.
Zhu Y; Qu C; Hong X; Jia Y; Lin M; Luo Y; Lin F; Xie X; Xie X; Huang J; Wu Q; Qiu X; Piao D; Xing Y; Yu T; Lu Y; Huang Q; Yu C; Jin J; Zhang Z
Cell Death Differ; 2019 Jan; 26(2):306-320. PubMed ID: 29748601
[TBL] [Abstract][Full Text] [Related]
32. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
Gotzmann J; Fischer AN; Zojer M; Mikula M; Proell V; Huber H; Jechlinger M; Waerner T; Weith A; Beug H; Mikulits W
Oncogene; 2006 May; 25(22):3170-85. PubMed ID: 16607286
[TBL] [Abstract][Full Text] [Related]
33. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
[TBL] [Abstract][Full Text] [Related]
34. Gamma-secretase complex-dependent intramembrane proteolysis of CD147 regulates the Notch1 signaling pathway in hepatocellular carcinoma.
Yong YL; Zhang RY; Liu ZK; Wei D; Shang YK; Wu J; Zhang ZY; Li C; Chen ZN; Bian H
J Pathol; 2019 Oct; 249(2):255-267. PubMed ID: 31215640
[TBL] [Abstract][Full Text] [Related]
35. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Zhang CZ
J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
[TBL] [Abstract][Full Text] [Related]
36. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
[TBL] [Abstract][Full Text] [Related]
37. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway.
Huang Q; Li J; Xing J; Li W; Li H; Ke X; Zhang J; Ren T; Shang Y; Yang H; Jiang J; Chen Z
J Hepatol; 2014 Oct; 61(4):859-66. PubMed ID: 24801417
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus core protein induces epithelial-mesenchymal transition in human hepatocytes by upregulating E12/E47 levels.
Tiwari I; Yoon MH; Park BJ; Jang KL
Cancer Lett; 2015 Jun; 362(1):131-8. PubMed ID: 25817725
[TBL] [Abstract][Full Text] [Related]
39. Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and E-cadherin.
Peroukides S; Bravou V; Alexopoulos A; Varakis J; Kalofonos H; Papadaki H
Histol Histopathol; 2010 Mar; 25(3):299-307. PubMed ID: 20054802
[TBL] [Abstract][Full Text] [Related]
40. AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways.
Xu MY; Chen R; Yu JX; Liu T; Qu Y; Lu LG
Cancer Lett; 2016 May; 374(2):241-9. PubMed ID: 26902423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
